Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

MRI Safe Implantable Device Market foreseen to grow exponentially over 2016 – 2024

(PharmaNewsWire.Com, March 02, 2017 ) Changing in the life style of population leads to various types of degenerative and chronic disease that affects the biological structure. In support to biological structure, various types of devices are implanted in human body that helps in replacing and enhancing the biological structure. These medical implants are man-made devices that are introduced in human body through surgical procedures and are left in the body after treatment. These devices are mostly implanted in geriatric population suffering from organ degeneration. During Magnetic Resonance Imaging (MRI) procedure some implant devices may fail to provide necessary treatment and compromise on patient safety which can lead to severe harm or death of the patient. To overcome this problem, many companies are trying to develop various type of implantable devices with non-ferromagnetic materials that overcome the harmful effect of MRI on patient.

Global MRI safe implantable device market is witnessing high growth owing to shifting lifestyle choices, high incidence of degenerative and chronic disease, rising geriatric population and technology advancement in implantable devices such as high-field MRI, software applications, superconducting magnets and open architecture. However, high cost of MRI safe implantable devices and inadequate reimbursement policies for MRI safe implantable devices may hamper the growth of MRI safe implantable device market over the forecast period.

Global MRI safe implantable device market is classified on the basis of magnetic field strength, product type, procedure type and end user.

Based on magnetic field strength, the global MRI safe implantable device market is segmented into the following:

High field MRI
Low-to-mid field MRI
Very-high-filed MRI
Ultra-high-filed MRI

Most of the orthopedic implants are made from non-ferromagnetic materials and helps in an escalating the number of patients for MRI procedure. On the other hand, in some orthopedic implants instances owing to formation of conductive loop there might be some MRI related heating problem. Due to widespread use of vascular access and catheters most of the patients may require MRI procedures which in turn exhibits the growth of global MRI safe implantable device market.

Depending on geographic region, global MRI safe implantable device market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America held the largest revenue share in the global MRI safe implantable device market followed by Europe and Asia Pacific owing to increase in geriatric population, technological advancements, increasing awareness for safe procedures and increase in the healthcare expenditure per capita. The developing nations in Asia Pacific, Middle East and Africa hold huge potential for growth in the global MRI safe implantable device market due to increase in chronic degenerative diseases along with healthcare expenditure.

Request to View Tables of Content @

Some of the key participating global players in global MRI safe implantable device market are Medtronic plc, Zimmer Holdings Inc., Abbott Laboratories, Cochlear Ltd., Biotronik, Boston Scientific Corporation, St. Jude Medical Inc, Smiths Medical, AbbVie, Inc., TriVascular2, Inc. Stryker Corporation, Smith And Nephew Plc, and Johnson & Johnson.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Buy Now: You can now buy a single user license of the report at

The final report customized as per your specific requirement will be sent to your e-mail id within 7-20 days, depending on the scope of the report.

Persistence Market Research

Rahul Singh


Source: EmailWire.Com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today! is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC